Hormone Therapy for Breast Cancer Linked With Lower Dementia Risk
July 17, 2024
July 17, 2024
PITTSBURGH, Pennsylvania, July 17 (TNSres) -- The University of Pittsburgh Medical Center issued the following news release:
Hormone modulating therapy (HMT) used for the treatment of breast cancer was associated with a 7% lower risk of developing Alzheimer's disease and related dementias later in life, according to a new study published today in JAMA Network Open.
The study, which is one of the largest of its kind, found that although HMT was linked with protection aga . . .
Hormone modulating therapy (HMT) used for the treatment of breast cancer was associated with a 7% lower risk of developing Alzheimer's disease and related dementias later in life, according to a new study published today in JAMA Network Open.
The study, which is one of the largest of its kind, found that although HMT was linked with protection aga . . .